The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension is a clinical research site located in Torrance, California, United States 90502.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Membranous Nephropathy, Nephrotic Syndrome.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension has 1 clinical trials on record, with 1 currently active. Their work covers Membranous Nephropathy, Nephrotic Syndrome.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.